Literature DB >> 19815840

Mobilization of PML/RARalpha negative peripheral blood stem cells with a combination of G-CSF and CXCR4 blockade in relapsed acute promyelocytic leukemia pre-treated with arsenic trioxide.

Friedrich Stölzel, Martin Wermke, Christoph Röllig, Christian Thiede, Uwe Platzbecker, Martin Bornhäuser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19815840      PMCID： PMC2805728          DOI： 10.3324/haematol.2009.016568

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  10 in total

1.  All-trans-retinoic acid in acute promyelocytic leukemia.

Authors:  M S Tallman; J W Andersen; C A Schiffer; F R Appelbaum; J H Feusner; A Ogden; L Shepherd; C Willman; C D Bloomfield; J M Rowe; P H Wiernik
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

2.  United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia.

Authors:  S L Soignet; S R Frankel; D Douer; M S Tallman; H Kantarjian; E Calleja; R M Stone; M Kalaycio; D A Scheinberg; P Steinherz; E L Sievers; S Coutré; S Dahlberg; R Ellison; R P Warrell
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

3.  Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients.

Authors:  C Niu; H Yan; T Yu; H P Sun; J X Liu; X S Li; W Wu; F Q Zhang; Y Chen; L Zhou; J M Li; X Y Zeng; R R Yang; M M Yuan; M Y Ren; F Y Gu; Q Cao; B W Gu; X Y Su; G Q Chen; S M Xiong; T D Zhang; S Waxman; Z Y Wang; Z Chen; J Hu; Z X Shen; S J Chen
Journal:  Blood       Date:  1999-11-15       Impact factor: 22.113

Review 4.  Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.

Authors:  J J van Dongen; E A Macintyre; J A Gabert; E Delabesse; V Rossi; G Saglio; E Gottardi; A Rambaldi; G Dotti; F Griesinger; A Parreira; P Gameiro; M G Diáz; M Malec; A W Langerak; J F San Miguel; A Biondi
Journal:  Leukemia       Date:  1999-12       Impact factor: 11.528

5.  Curative strategies in acute promyelocytic leukemia.

Authors:  Martin S Tallman; Jessica K Altman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2008

Review 6.  Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Authors:  Miguel A Sanz; David Grimwade; Martin S Tallman; Bob Lowenberg; Pierre Fenaux; Elihu H Estey; Tomoki Naoe; Eva Lengfelder; Thomas Büchner; Hartmut Döhner; Alan K Burnett; Francesco Lo-Coco
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

7.  Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis.

Authors:  Pau Montesinos; Joaquín Díaz-Mediavilla; Guillermo Debén; Virginia Prates; Mar Tormo; Vicente Rubio; Inmaculada Pérez; Isolda Fernández; Maricruz Viguria; Chelo Rayón; José González; Javier de la Serna; Jordi Esteve; Juan M Bergua; Concha Rivas; Marcos González; Jose D González; Silvia Negri; Salut Brunet; Bob Lowenberg; Miguel A Sanz
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

Review 8.  CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers.

Authors:  J A Burger; A Peled
Journal:  Leukemia       Date:  2008-11-06       Impact factor: 11.528

9.  Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

Authors:  Bruno Nervi; Pablo Ramirez; Michael P Rettig; Geoffrey L Uy; Matthew S Holt; Julie K Ritchey; Julie L Prior; David Piwnica-Worms; Gary Bridger; Timothy J Ley; John F DiPersio
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

10.  Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.

Authors:  John F DiPersio; Edward A Stadtmauer; Auayporn Nademanee; Ivana N M Micallef; Patrick J Stiff; Jonathan L Kaufman; Richard T Maziarz; Chitra Hosing; Stefan Früehauf; Mitchell Horwitz; Dennis Cooper; Gary Bridger; Gary Calandra
Journal:  Blood       Date:  2009-04-10       Impact factor: 22.113
  10 in total
  2 in total

1.  CXCR4 chemokine receptor signaling induces apoptosis in acute myeloid leukemia cells via regulation of the Bcl-2 family members Bcl-XL, Noxa, and Bak.

Authors:  Kimberly N Kremer; Kevin L Peterson; Paula A Schneider; X Wei Meng; Haiming Dai; Allan D Hess; B Douglas Smith; Christie Rodriguez-Ramirez; Judith E Karp; Scott H Kaufmann; Karen E Hedin
Journal:  J Biol Chem       Date:  2013-06-24       Impact factor: 5.157

2.  Tissue-Nonspecific Alkaline Phosphatase Is Required for MC3T3 Osteoblast-Mediated Protection of Acute Myeloid Leukemia Cells from Apoptosis.

Authors:  Rosalie M Sterner; Kimberly N Kremer; Amel Dudakovic; Jennifer J Westendorf; Andre J van Wijnen; Karen E Hedin
Journal:  J Immunol       Date:  2018-06-18       Impact factor: 5.422
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.